Company Confirms Proceeds Utilization of Commercial Paper for Quarter Ended June 30, 2026
The company has confirmed the utilization of proceeds generated from its Commercial Papers (CPs) for the quarter ending June 30, 2026.A certificate issued by the Chief Financial Officer of the organization confirms that the funds raised through the issuance of Commercial Papers were applied strictly for the purposes outlined in the respective offer documents. The confirmation also states that all other listing conditions associated with the CPs were adhered to during this period.
This declaration addresses the framework for the listing of CP and reaffirms adherence to specified requirements concerning the utilization of the proceeds of these debt instruments, as mandated under relevant operational guidelines.
ARTEMISMED Stock Price Movement
Today, Artemis Medicare Services Limited shed value, finishing the trading session at ₹273.00 after slipping 0.85% in post-market activity. The stock experienced movement throughout the day, trading within a narrow band that saw a high of ₹278.35 and a low of ₹271.45.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.